Cargando…
N,N-dimethylacetamide targets neuroinflammation in Alzheimer’s disease in in-vitro and ex-vivo models
Alzheimer’s disease (AD) is a chronic degenerative brain disorder with no clear pathogenesis or effective cure, accounting for 60–80% of cases of dementia. In recent years, the importance of neuroinflammation in the pathogenesis of AD and other neurodegenerative disorders has come into focus. Previo...
Autores principales: | Wei, Zeng-Hui, Koya, Jagadish, Acharekar, Nikita, Trejos, Jesus, Dong, Xing-Duo, Schanne, Francis A., Ashby, Charles R., Reznik, Sandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151369/ https://www.ncbi.nlm.nih.gov/pubmed/37127686 http://dx.doi.org/10.1038/s41598-023-34355-w |
Ejemplares similares
-
2-Cyano-N,N-dimethylacetamide
por: Liu, Shan, et al.
Publicado: (2012) -
Urea–N,N-dimethylacetamide (1/1)
por: Fernandes, Philippe, et al.
Publicado: (2008) -
Recent Uses of N,N-Dimethylformamide and N,N-Dimethylacetamide as Reagents
por: Le Bras, Jean, et al.
Publicado: (2018) -
Benzene-1,4-dicarboxylic acid–N,N-dimethylacetamide (1/2)
por: Guo, Xia, et al.
Publicado: (2009) -
N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment
por: Ghayor, Chafik, et al.
Publicado: (2017)